在乳腺癌中,Palbociclib可能具有TLR介导的免疫刺激作用
Ibrahim Bayav1, Sevda Sağ1, Huriye Ergezgin2
1Department of Medical Biology, Faculty of Medicine, Pamukkale University, Kınıklı, Denizli, Turkey.
Molecular biology reports
|November 26, 2025
概括
一种CDK抑制剂的Palbociclib可以阻止乳腺癌细胞循环并诱导细胞亡. 这项研究发现,它也影响了托尔类受体 (TLR) 表达,可能会激活癌细胞中的免疫反应.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 帕尔博西克利布是一种用于ER+/HER2-乳腺癌的CDK抑制剂.
- 它通过抑制癌细胞中的细胞循环来起作用.
- 收费类受体 (TLRs) 在免疫反应中起着至关重要的作用.
研究的目的:
- 为了研究palbociclib对TLR表达的影响.
- 分析palbociclib对细胞周期和亡途径的影响.
- 为了评估这些影响在MCF-7和MDA-MB-231乳腺癌细胞系.
主要方法:
- 实时定量PCR (qRT-PCR) 用于评估基因表达 (TLR 1-10,CDK4/6,BCL-2,Bax,Cas-3) 的情况.
- 西部斑点分析用于测量总和化视网膜母细胞瘤 (RB) 蛋白水平.
- 治疗MCF-7和MDA-MB-231细胞系使用palbociclib.
主要成果:
- 在两种细胞系中,Palbociclib降低了CDK4/6和酸化RB (pRB) 表达.
- 与亡相关的基因表达发生了变化:Bax和Cas-3增加,BCl-2减少.
- 观察到对托尔类受体 (TLR) 基因表达的调制.
结论:
- 帕尔博西克利布抑制细胞循环的进展,并诱导乳腺癌细胞的亡.
- 帕尔博西克利布治疗改变了托尔类受体 (TLR) 的表达.
- 这些发现表明palbociclib可能会通过TLRs激活乳腺癌中的免疫反应.
相关概念视频
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K


